BEUDAMED
    FDA Adverse Event Injury Summary report: N

    GELSYN-3

    MDR report key: 15103961 · Received July 25, 2022

    Report

    Report Number
    MW5111102
    Event Type
    Injury
    Date Received
    July 25, 2022
    Report Date
    July 21, 2022
    Manufacturer
    IBSA FARMACEUTICI ITALIA SRL
    Product Code
    MOZ
    Adverse Event
    Yes
    Report Source
    Voluntary report
    Reporter Location
    PA, US
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Description of Event or Problem · 0

    THE PT REPORTED ANKLE SWELLING MD TO INJECT 1 SYRINGE INTRA-ARTICULARLY INTO THE AFFECTED KNEE(S) EACH WEEK FOR 3 WEEKS.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1432954 GELSYN-3 ACID, HYALURONIC, INTRAARTICULAR MOZ IBSA FARMACEUTICI ITALIA SRL

    Patients

    Seq Age Sex Outcome Treatment
    1 Female CRESTOR TAB 5 MG| DEXILANT CAP 60 MG DR| DOXEPIN HCL CAP 50 MG| SYNTHROID TAB 137 MCG